Pennsylavnia

What are some of Geisinger’s priorities with Regeneron collaboration?

Geisinger Health System announced this week that it’s working with Regeneron Pharmaceuticals  (NASDAQ: REGN) in a project to use genetic samples from more than 100,000 volunteers to identify and validate associations between genes and human disease. The move reflects Geisinger’s efforts to advance genomic analysis from the research stage to the point where it is […]

Pharma

NuPathe gets FDA approval for migraine patch

Migraine sufferers (and no doubt some investors) will be feeling some relief tonight after NuPathe (NASDAQ: PATH) secured approval from the U.S. Food and Drug Administration for its lead product — the first skin patch to deliver sumatriptan, a widely used migraine medication. The delivery system is aimed at people who get  migraines and experience […]

presented by